NASDAQ · DRTSW
Alpha Tau Medical Ltd. Warrant financials
$4.10+4.59%
Close Sep 28, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q4 '25 Dec 31 | Q4 '24 Dec 31 | Q4 '23 Dec 31 | Q4 '22 Dec 31 |
|---|---|---|---|---|
| Revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Gross margin | — | — | — | — |
| Operating income | — | — | — | — |
| Net income | — | — | — | — |
| Net margin | — | — | — | — |
| Diluted EPS | — | — | — | — |
| EBITDA | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating cash flow | — | — | — | — |
| Free cash flow | — | — | — | — |
| Diluted shares | 80.6M | 69.9M | 69.4M | 63.5M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|
| Cash & equivalents | $12.2M | $13.7M | $12.7M | $5.8M |
| Short-term investments | $60.9M | $45.9M | $69.1M | $98.7M |
| Total debt | $6.4M | $5.6M | $5.6M | $0.00 |
| Total assets | $105.7M | $86.2M | $107.4M | $120.1M |
| Total liabilities | $28.6M | $23.5M | $22.9M | $8.9M |
| Shareholders' equity | $77.1M | $62.7M | $84.5M | $105.7M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology